Bows Pharmaceuticals AG Report issue

For profit Phase 2
Founded: Zug Switzerland (2002)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2009
NCT00990444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

insulin human (humulin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1